1. Treat a major's staged earn-in as an M&A ceiling, not just funding
The repeatable method
- When a junior signs a major to a staged earn-in (milestone payments for a project interest), separate the two effects: it funds the studies, but it also gives the funding partner a right of first refusal over the whole asset.
- Ask the killer question up front: "How do you maintain competitive tension in the room with [the major] there?" A partner who can "come over the top with a counter" deters rival bidders — no one launches an offer they know will just get topped.
- Value the ceiling explicitly: the earn-in's implied deal price often caps the stock below the study's NAV (here Rio's $250mn-for-20% implied ~$6/share vs a much higher PEA NAV). So the partner's presence is a discount, not only a subsidy.
- Therefore re-price a partner exit as bullish: it removes the ceiling and reopens a competitive auction — the opposite of the market's first reaction.
Here: Paulo's "biggest question since they signed the Nuton deal" was maintaining competitive tension with Rio in the room. When Rio's Nuton walked, "Rio is out of the way" and ALDE's 80%-owned Altar is "up for grabs" for South32, Glencore, Sibanye and other majors — a positive he says "the market does not realize."
Watch for
- Junior-major earn-ins where the implied deal value sits below study NAV; a partner exit that the tape reads as bad news but actually reopens the bid.
2. Buy the walkaway overreaction when the exiting party's problems are internal
The repeatable method
- When a partner walks and the stock gaps down, split the causes: is something wrong with the asset, or something wrong with the party leaving?
- Interrogate the leaver's own behavior across other decisions. A pattern of cost-cutting/retrenchment (mothballed projects, refused pro-rata, travel bans, a new cost-focused CEO) says the exit is about them, not the deposit.
- Check the study still stands ("everything from the PEA stands") and crosscheck with management directly — but form your own conclusions, not theirs.
- If the asset is intact and the leaver is the problem, treat the panic as a gift and pre-place bids into the flush ("channel your inner Shrub… we give thanks").
Here: ALDE fell -30% on historic volume; Paulo diagnosed the cause as RIO ("Rio seems lost" — Jadar mothballed, ASCU pro-rata refused, travel ban, only ~#9 in copper), not Altar, and filled bids in the $2.60s. The stock was still +60% on the year and back to its Oct-8 close.
Watch for
- A partner exit paired with visible internal retrenchment at the leaver; a study that survives intact; capitulation volume into a level where you can pre-place bids.
3. The staged-earn-in funding playbook — let the major pay for your PEA
The repeatable method
- Favor juniors that fund expensive de-risking studies (drilling → MRE → PEA → PFS) with a partner's milestone payments rather than dilutive equity — especially when junior capital markets are shut.
- Score the asymmetry: if the partner walks mid-way, the junior keeps the completed work and the partner eats its sunk cost. "Nuton got nothing in return for their US$30mn sunk cost."
- Prize capital efficiency as a management-quality signal: measure NAV delivered per dollar of equity burned. "Any junior that delivers a $2bn NPV PEA burning only C$30mn of raised equity in a 2-year timeframe is… rare."
Here: ALDE's Nov-2024 Nuton deal ($250mn staged for 20%) funded $30mn of drilling + a PEA that proved a $2bn+ mine — "a master stroke… when the capital markets for junior miners were largely closed" and copper was $4 vs $5/lb.
Watch for
- Partner-funded study pipelines; who eats the sunk cost on a walk; NAV-delivered-per-share-issued as the efficiency metric.
4. Re-rate the NAV mechanically off the forward study's price deck
The repeatable method
- Note the commodity price deck a current study uses, then the higher long-term Street deck the next study (PFS/FS) will likely adopt.
- Recompute NAV at the forward deck — the uplift is close to automatic (higher metal price flows to cashflow and NPV) before any operational improvement.
- Express the stock as a fraction of that forward NAV. A very low x-NAV at the higher deck is the takeout margin an acquirer can capture by simply waiting for the study to re-print at the new price.
Here: a PFS at $5/lb copper (the long-term Street price) takes Altar's NPV to $3.3bn and ALDE's NAV from $1.6bn to $2.6bn — so ALDE trades ~0.15x NAV at $5 Cu (0.25x at the PEA's $4.35). "Why not just buy ALDE and do all the scoping and a Feasibility Study your way?"
Watch for
- A study printed on a conservative deck with a higher long-term price on the horizon; the x-NAV gap between the two decks as the takeout cushion.
5. Value the neighbor — the shared-infrastructure takeout template
The repeatable method
- Map the adjacent projects and their owners. A district-scale deposit next to a major's own project is worth more to that major than to anyone else.
- Quantify the synergy as shared infrastructure: "one road, power line, and water supply is cheaper than two." A neighbor can underwrite a higher bid because it dilutes fixed capex across two orebodies.
- Use precedent takeout templates (adjacent juniors combined by a strategic to share infrastructure) to identify the most probable acquirer before the auction is obvious.
Here: GLNCY (Glencore) owns neighboring El Pachon in Argentina — "Why not team up with Glencore at El Pachon down the road like Filo did with Jose Maria?" The Filo/Jose Maria infrastructure-sharing takeout is the explicit template for an ALDE outcome.
Watch for
- A junior adjacent to a major's project in the same district; recent shared-infrastructure M&A precedents (Filo/Jose Maria) that name the likely bidder.
6. Read non-brokered premium placements as a dilution-discipline tell
The repeatable method
- Pull the junior's raise history. Distinguish dilutive brokered discounted deals from non-brokered private placements done at (or above) the market price to strategic/insider buyers.
- Premium, non-brokered raises signal aligned insiders and a management that "knows how to stretch a dollar" — a proxy for capital discipline through the development cycle.
- Separate urgency from need: cash runway + a small, deferrable study cost means capital "can be raised in 3-6 months, not now" — and there are non-equity levers (e.g. a small NSR royalty to a streamer/PE) that fund the study without diluting holders.
Here: ALDE's raises were all non-brokered placements at a premium — C$20.5mn in Sep-23 at 88c (South32 paid C$1.01), 70c warrant exercises, South32's C$14mn Aug-22 entry. With $10mn cash and only ~$20-30mn needed for the PFS, "a 0.5% net smelter royalty could be signed quickly by a streamer or PE" — no forced equity raise.
Watch for
- Non-brokered placements at/above market to strategics/insiders; adequate cash runway that turns the next raise into a choice; royalty/streaming levers that avoid dilution.